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THE EFFECTS OF THE MENSTRUAL CYCLE ON AGILITY 
KARIM G. KHENISER 
ABSTRACT 
 
It has long been speculated that the menstrual cycle affects athletic performance. Whether 
athletic performance is impacted by menstrual cycle phase is dependent upon an array of 
factors: the type of activity (i.e., aerobic or anaerobic); oral contraceptive (OC) use; and, 
possibly, if mental processing is required during the execution of the task. Prior research 
has indicated that alterations in estradiol (E2) affects cognitive performance. However, 
there is a paucity of information about whether E2 modulates the speed of cognitive 
processing in a sports setting, which may cause alterations in sport performance 
throughout the menstrual cycle. Additionally, variations in E2 levels during the menstrual 
cycle are associated with changes in joint laxity, which may translate into changes in 
quick and powerful movements, such as multidirectional running patterns that are 
required in many sports. PURPOSE: The present study aimed to deduce if fluctuations in 
E2 influence agility performance in the reactive agility test (RAT) and T-Test. The 
former requires mental processing during its execution, whereas the T-Test does not. 
METHODS: Subjects (n=10; BMI 22.4 ± 1.4-kg/m2; weight 61.3 ± 5.6-kg; age 24.2 ± 5-
years; height 165.58 ± 8.29-centimeters) were tested on the RAT and T-Test, during mid-
cycle ([MC], high E2) and the early follicular phase ([EF], low E2) of the menstrual 
cycle. Subjects monitored urine levels of luteinizing hormone (LH), to determine when 
the surge in E2 occurs and correspondingly the MC test timing. RESULTS: With respect 
to the T-Test, the results indicated that the subjects were significantly faster during EF, 
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relative to MC (12.3 ± 0.89-s vs. 12.56 ± 0.90-s, p=0.007). However, there were no 
significant differences in RAT agility times between EF and MC. CONCLUSION: 
Cognitive function (i.e., mental processing) during the execution of sports-related 
movements is not affected, but joint laxity and the subsequent alterations in biomechanics 
may hinder the ability to execute athletic maneuvers that require sudden changes in 
direction. Strength and conditioning coaches and athletes should conduct agility trials 
during EF to have greater consistency between trials; especially when assessing the 
efficacy of a strength and conditioning paradigm.
  






Substantial interest has been devoted to studying how the menstrual cycle may 
affect athletic performance and mediate injury risk. As it pertains to the latter, there is 
more than a three-fold higher incidence of anterior cruciate ligament injuries (ACL) 
among women. The mechanisms that are causal to ACL-related injuries are 
multifactorial: sexual dimorphism in muscular strength, morphological differences, and 
the exposure to pulsatile secretions of ovarian hormones. Of note, the latter has garnered 
an overarching degree of attention, when studying the etiology of ACL injuries. Although 
the menstrual cycle is characterized by cyclic changes in hormones, to delineate the 
effects of endogenous hormones on injury risk, three distinct and segmented hormonal 
milieus are isolated during the menstrual cycle and are of critical importance. 
Specifically, estrogen (E) levels are significantly attenuated, increased, and increased 
during the early follicular phase (EF), mid-cycle (MC), and the mid-luteal phase (ML), 
respectively. Moreover, progesterone (PG) concentrations are low during EF and MC and 
upregulated in the ML phase, while testosterone (T) levels are elevated during MC.
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One prevailing thought is that these perturbations in endogenous hormones lead to 
increases in knee joint laxity, which may alter biomechanical patterns (e.g., increased 
knee valgus during landing) and contribute to debilitating injuries (Shultz et al., 2012a). 
Similarly, reciprocal decreases in musculotendinous stiffness (change (Δ) in force/Δ 
length), which is specifically related to the menstrual cycle, also represents one 
mechanism that heightens risk to injury (Shultz, Schmitz, & Beynnon, 2011).  
Although the aforementioned has yielded pertinent information, with regards to 
ascertaining the precipitating factors that lead to ACL injuries, there appears to be no 
conclusive and significant evidence to indicate that the menstrual cycle affects athletic 
performance. To date, muscular strength has been shown to be unaltered by fluctuations 
in endogenous hormones (Dibrezzo, Fort, & Brown, 1991; Elliott, Cable, Reilly, & 
Diver, 2003; Friden, Hirschberg, & Saartok, 2003; Janse de Jong, Boot, Thom, Ruell, & 
Thompson, 2001; Lebrun, McKenzie, Prior, & Taunton, 1995), and substrate kinetics is 
equally unaffected by the menstrual cycle during aerobic physical activity, as evidenced 
by novel well-controlled trials (Horton, Miller, & Bourret, 2006; Horton, Miller, Glueck, 
& Tench, 2002; Jacobs, Casazza, Suh, Horning, & Brooks, 2005; Smekal et al., 2007). 
However, higher concentrations of E in fertile females and infusion of E in post-
menopausal women improves verbal memory (i.e., cognitive function) and laxity 
modulates biomechanical patterns (Rosenberg & Park, 2002; Wolf et al., 1999); 
consequently, it is conceivable that the former may affect agility times during open-
skilled (requires mental processing) in relation to closed-skilled (does not require mental 
processing) agility movements, whilst laxity may affect biomechanical patterns. Taken 
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together, agility can be modified by impaired mental processing and increased joint 
laxity.  
Thus, given that agility is required in almost all sport and significantly influences 
athletic performance, it is prudent to elucidate how it varies across the menstrual cycle. In 
doing so, scientists and strength coaches can more readily delineate when to best conduct 
agility tests and effectively prescribe individualized strength and conditioning paradigms. 
More importantly, cycle phase can serve as a predictor of athletic performance, and 
agility times can serve as an ancillary marker of increases in knee laxity (i.e., increased 
laxity may be paralleled by decreases in agility times, given that biomechanics is altered 
by lax tissues). The purpose of this investigation was to determine if agility is affected by 
the menstrual cycle, by conducting agility drills during MC and EF. The hypothesis was 
that agility performance will be hindered during MC, relative to EF, due to alterations in 
knee laxity, cognitive function, and biomechanical patterns.
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CHAPTER II 
REVIEW OF LITERATURE 
 
   
The menstrual cycle of the female reproductive system is marked by two distinct 
phases: the considerable inter-individual variability of the follicular phase (FP) and the luteal 
phase (LP), which is usually 12-14 days in length (Practice Committee of the American 
Society for Reproductive Medicine [PCASRM], 2012). Lower mean resting plasma 
concentrations of E and PG during the FP differentiates the aforesaid phases. Further, the E 
peak occurs during the latter portion of the FP and there are a diverse group of estrogens: 
17B-estradiol (E2), estrone, and estriol, which are formed by androgenic precursors 
(Coelingh Bennink, 2004); E2 is the principal E and PG peaks roughly 6-8 days post-
ovulation (PCASRM., 2012). From a physiological perspective, the phases serve as 
intermediates to one another and their temporal nature is marked by the development of the 
dominant follicle in the FP and an active corpus luteum in the LP (American College of 
Sports Medicine [ACSM], 2006). Specifically, the FP denotes the time from menses to 
ovulation, whereas the LP is defined as the interval from ovulation until the onset of the next 
menses. Each phase is arbitrarily defined as being 14 days in duration; however, this can 
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fluctuate based on habitual physical activity, use of oral contraceptives (OC), and energy 
consumption. For example, women who adhere to an exercise regimen frequently display an 
elongated FP and a condensed LP (Widmaier, Raff, & Strang, 2011). There is also a high 
prevalence of anovulation in women who are recreationally active. However, maintenance of 
luteinizing hormone (LH) pulsatility and ovarian function is related to energy availability 
rather than the stress of exercise (Loucks & Thuma, 2003; Loucks, Verdun, & Heath, 1998). 
Subsequently, consuming an adequate energy entake (i.e., 30kcal/kg of lean body mass), 
even in the face of heightened levels of energy expenditure, preserves ovarian function 
(Loucks & Thuma, 2003).  
2.1 Effects of the Menstrual Cycle on Substrate Kinetics 
 
With the aforementioned changes in circulating hormones, the menstrual cycle affects 
a myriad of physiological parameters, which could in-turn affect athletic performance (Janse 
de Jonge, 2003; Lebrun, 1993; Shultz, et al., 2012b). For instance, absolute and relative 
maximal oxygen consumption (Vo2max) are significantly lower during the LP, relative to the 
FP (Lebrun et al., 1995). Similarly, endogenous hormonal perturbations during the menstrual 
cycle have been shown to alter substrate utilization during aerobic physical activity, such that 
free- fatty acid (FFA) oxidation is heightened during ovulation and/or the LP (Ashley, 
Bishop, Smith, Reneau, & Perkins, 2000; Bonen, Haynes, & Graham, 1991; Casazza, et al., 
2004; Devries, Hamadeh, Phillips, & Tarnopolsky, 2006; Suh, Casazza, Horning, Miller, & 
Brooks, 2003). However, the results were marred by confounding variables. For instance, 
Devries et al. (2006) included women on triphasic OC and subjects not on OC; relative to OC 
subjects, women not on OC had higher circulating concentrations of E2 and PG during the 
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LP and elevated levels of E2 and T during FP, but no differences were noted between the 
groups, with regards to carbohydrate storage and utilization. Given that the aforementioned 
study combined subjects who were and weren’t on OC into one group, the results from this 
study should be interpreted with caution. On the other hand, longitudinal and/or well 
conducted trials that controlled for cofounding variables (e.g., food intake, which alters 
substrate utilization) have demonstrated no deviations in substrate utilization during the 
menstrual cycle (Horton et al., 2006; Horton et al., 2002; Jacobs et al., 2005; Smekal et al., 
2007). 
2.2 Effects of the Menstrual Cycle on the Anabolic Response Post-Exercise 
 
Additionally, the anabolic stimulus post-exercise may be affected during the LP, as 
demonstrated by increased growth hormone (GH) levels in response to a resistance training 
bout (Nakamura, Aizawa, Imai, Kono, & Mesaki, 2011). Enea et al. (2009) observed 
increases in T and dehydroepiandrosterone after a prolonged exercise session and Wingate 
test, but no influence of menstrual cycle phase was observed among the cohort. However, the 
results were confounded by predetermined test timing and E and PG levels were not assayed. 
T concentrations are elevated during ovulation and, therefore, may play a role in strength 
development (Phillips, Rook, Siddle, Bruce, & Woledge, 1993; Rutherford & Jones, 1992; 
Sarwar, Niclos, & Rutheford, 1996; Shultz, Sander, Kirk, & Perrin, 2005). However, Elliot et 
al. (2003) did not note a difference in the concentration of testosterone ([T]) during the 
menstrual cycle and no corresponding alterations in isometric maximal voluntary contraction 
(MVC) in the first dorsal interosseous muscle were observed.  Although unlikely, fluctuating 
E and PG levels may play a role in the expression of muscular strength and, therefore, agility 
in women; differences in E receptor mRNA levels, and higher E concentrations could 
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attenuate E receptor downregulation (Devries et al., 2006; Wiik et al., 2003). PG could 
counteract the effects of E on MVC, but in postmenopausal women where the concentration 
of PG is low, muscle weakness is still present (although muscle weakness can be attributed to 
the effects of sarcopenia) (Phillips, Rook, Siddle, Bruce, & Woledge, 1993; Rutherford & 
Jones, 1992; Sarwar, Niclos, & Rutheford, 1996; Shultz, Sander, Kirk, & Perrin, 2005). Elliot 
et al. (2003) also notes that bioavailable concentrations of free and albumin-bound E2 
fractions did not change throughout the cycle even though total E2 levels fluctuated. This 
indicates that E remains bound to sex hormone binding globulin (SHBG) and is, therefore, 
unlikely to influence acute muscle strength.   
2.3 Mediators of Agility 
 
Although additional research is needed to delineate if fluctuating hormones influence 
substrate utilization and the anabolic milieu post-exercise, its effect on agility may be 
significant, especially if it affects mediators of agility. Agility has been traditionally used as 
an umbrella term that denotes any swift alteration in body positioning during athletic 
competition. Whether the deviation in body position is preplanned, influenced by auditory 
stimuli (firing a gun during a 100-meter sprint), or by a visual stimulus is irrelevant 
(Sheppard & Young, 2006a). Herein, the definition proposed by Sheppard et al. (2006a) will 
be utilized to describe agility, which is denoted by a swift change of direction as a result of 
an external stimuli. Furthermore, an emphasis is also placed on open-skill movements, which 
they describe as being a countermovement that is influenced by a non-rehearsed stimulus 
(e.g., evading an oncoming linebacker in football).  
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The determinants of agility are vast (strength, power, anticipation, recognition, 
reaction time, body composition, stature, etc.), and an explanation of each modulator of 
agility would be impractical. Therefore, this review will be confined to the most pertinent 
regulators of agility. There is some ambiguity as to whether sprinting correlates with indexes 
of agility (Sekulic, Spasic, Mirkov, Cavar, & Sattler, 2013; Tsitskarsis, Theoharopoulus, & 
Garefis, 2003). The dichotomy between Tsitskarsis et al. (2003) and Sekulic et al. (2013) 
with regards to the correlation between speed and agility could be the result of divergent 
testing modalities. Sekulic et al. (2013) utilized predetermined change of direction points 
(e.g., T-Test) whereas Tsitskarsis et al. (2003) employed more sport specific movements. 
Further, Young et al. (2002) state that test specificity influences the degree to which two 
measures are correlated. For example, a higher correlation between depth jump height and 
change of direction is present because of the similar neural discharge patterns.  
 In relation, strength and power influence agility more readily in sports that require 
changes of direction in a more confined area (e.g., racquetball court); the association is 
curtailed as the distance required to execute the change of direction movement is increased 
(e.g., soccer player trying to move past a defender over a 10 yard distance) (Sheppard et al., 
2006a). Congruently, Sekulic et al. (2013) noted a strong correlation between power and 
agility. A more pronounced relationship was noted between leg reactive strength (stretch-
shortening cycle) and change-of-direction performance, but concentric leg extension power 
did not demonstrate a significant relationship (Young, James, & Montgomery, 2002).  
Furthermore, cognition (reaction speed, recognizing movement cues) are undervalued 
components of agility in the sporting community. Processing information and speed of 
reaction are integral in sports such as football, where an offensive player must ascertain the 
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opposing players speed, position, and their intersection prior to initiating a change of 
direction movement (Sheppard et al., 2006a). It is plausible that impairments in cognition 
may result in differentiated agility times during the menstrual cycle because it may affect 
cognitive function (Rosenberg et al., 2002; Wolf et al., 1999). Even minute defficiencies in 
mental processing can have drastic implications during athletic competition. For example, an 
inability to recognize movement cues of an opposing football player can result in an inability 
to evade an oncoming defender. No study has investigated if cognitive function can 
significantly alter agility times in open skilled tests (e.g., RAT). Likewise, no information is 
present as to how the menstrual cycle can impact reaction time and recognition. Rosenberg et 
al. (2002) only measured how the menstrual cycle influences verbal memory, which has no 
bearing on athletic performance. However, verbal memory, reaction time, and recognition 
skills constitute cognitive performance. Therefore, an impairment in verbal memory during 
EF may also be paralleled by impaired reaction time and recognition. Given that agility is 
affected by a wide array of variables, any performance decrements during the menstrual 
cycle in any of the aforementioned mediators of agility would impede an athlete’s ability to 
change direction.  
A more in depth review of indices of strength and neuromuscular control during the 
menstrual cycle is warranted; hamstring eccentric and concentric isokinetic force have been 
shown to correlate with timed agility tests, with a more significant correlation (r= .58) being 
noted in the former (Anderson et al., 1991). Eccentric forces generated during isokinetic 
testing would likely predict timed agility runs to a greater extent because eccentric 
movements are involved during deceleration, which is prevalent in agility tests (Sheppard et 
al., 2006a).  
  
  10 
 
2.4 Effects of the Menstrual Cycle on the Neuromuscular System 
 
Trials that favor an effect of menstrual cycle phase on neuromuscular control and/or 
indexes of strength are confounded by methodological shortcomings. In eumenorrheic 
subjects not on OC (n=10), a study found that isometric quadriceps MVC and handgrip 
strength were highest during MC, defined as day 12-18 of the menstrual cycle, was more 
fatigable, and had a longer half relaxation time from twitch and fused tetanus (denotes the 
ability of the sarcoplasmic reticulum to sequester calcium) (Sarwar et al., 1996). The cohort 
was tested during two full cycles, during five different phases (i.e., EF, between days 1-7; 
mid-follicular (MF), between days 7-12; MC, between days 12-18; ML, between days 18-21; 
and late luteal (LL), between days 21-32). A Jamar hydraulic hand dynamometer, 
conventional strength testing chair, stimulated contractions, and an adapted Burke protocol 
quantified grip strength, quadriceps MVC (percutaneous twitch superimposition [PTS] was 
utilized), contractile properties, and fatigability, respectively. Although the researchers 
studied 20 total subjects across two cycles, the data from this study lacks validity because the 
researchers did not assay hormonal levels and instead estimated cycle phase by counting 
backward from onset of menses. Thus, the study could have been confounded by anovulatory 
women and an inaccurate interpretation of cycle phase. Also, in trained (n=10) and untrained 
(n=12) women who were not on OC, researchers noted significant increases in muscle force 
values of the adductor pollicis muscle (AP) during the FP and a decline in maximal voluntary 
force (MVF) during ovulation (Phillips, Sanderson, Birch, Bruce, & Woledge, 1996). The 
trained populations were members of a rowing club, while the untrained subjects were 
largely sedentary. MVF measurements were ascertained by placing a transducer between the 
thumb and index finger and adducting the thumb for six to nine maximal contractions. 
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However, while the researchers detected ovulation via basal body temperature (BBT) and LH 
urinary kits and measured E2 levels, they failed to utilize PTS during the measurement of 
MVF. Consequently, they were not able to ascertain if the subjects exerted maximal effort. 
Moreover, a study noted that the muscle stretch reflex response of the rectus femoris was 
lowest during the periovulatory phase, which is an indicator of neuromuscular control 
(Casey, Hameed, & Dhaher, 2014). Although, as with the antecedent studies, the results are 
confounded by several design flaws: the authors did not utilize urinary LH strips; PTS was 
not incorporated; and it was not a longitudinal study (given that they assessed OC and non-
OC subjects separately). Lastly, motor unit firing frequency was higher for the vastus 
medialis in relation to the vastus medialis oblique, and there was a phase effect such that 
firing rates were more pronounced in the LL phase in comparison to the EF phase (Tenan, 
Peng, Hackney, & Griffin, 2013). However, endogenous hormonal levels were not assayed 
and the authors did not use PTS during MVC contractions. 
Other studies have failed to note a difference in muscular strength during the course 
of the menstrual cycle (Dibrezzo et al., 1991; Elliot et al., 2003; Fridén et al., 2003; Janse de 
Jong et al., 2001; Lebrun et al., 1995). Contemporary evidence has indicated that the 
neuromuscular system is not affected by the menstrual cycle (Abt, et al., 2007; Hertel, 
Williams, Olmsted-Kramer, Leidy, & Putukian, 2006). Excluding Hertel et al. (2006) who 
predicted the day of ovulation, well-conducted trials provide credence that any deviation in 
timed agility tests during the menstrual cycle would be independent of deviations in 
neuromuscular performance, across the menstrual cycle. Consequently, perturbations in T, E, 
and PG do not appear to affect muscular strength.  
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2.5 Effects of the Menstrual Cycle on Joint Laxity  
 
Although knee sprains can be significantly influenced by a multitude of variables 
(i.e., sexual dimorphism in strength and morphological characteristics, etc.) (Hewett, 2000), 
knee joint laxity and the corresponding knee injury rate (e.g., ACL injuries) is also largely 
affected by endogenous fluctuations in E. Specifically, heightened physiologic levels of E2 
induce reductions in fibroblast proliferation and collagen synthesis (Liu, Al-Shaikh, 
Panossian, Finerman, & Lane, 1997; Yu, Liu, Hatch, Panossian, & Finerman, 1999; Yu, 
Panossian, Hatch, Liu, & Finerman, 2001), while PG has an antagonistic effect. Thus, 
possible perturbations in agility performance during the menstrual cycle may also be 
paralleled by an increased injury risk. For example, if agility performance is hindered MC, 
when knee injuries are most prevalent, then strength and conditioning programs can reduce 
the workload and/or intensity during this isolated time period, to reduce the risk of injuries.  
Trials that either failed to measure hormonal levels or conducted testing at arbitrary 
time points have demonstrated either increased knee joint laxity during the LP or no 
deviations. In a smaller sample size (n=7, age 26.9 ± 4.2-years), subjects were tested during 
predetermined time intervals (i.e., day 1, 10-13, and 20-23). As a consequent, hormonal 
concentrations may be significantly varied, as peak levels may be attained at different time 
points (e.g., ovulation may occur on day 14 or 15). Laxity measurements were attained via 
the KT-200 knee arthrometer (KTNM). The results indicated that ACL laxity was greatest 
during phase II (i.e., days 10-13) and III (i.e., days 20-23), relative to phase I (i.e., day 1), 
with the highest values occurring during phase III (Heitz, Eisenman, Beck, & Walker, 1999). 
Similarly, in a recreationally active cohort (n=70, age 21.5 ± 2.6-years), Shultz et al. (2010) 
noted significant differences in anterior knee laxity between the fifth and eighth luteal days, 
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such that they were higher during the former. The aforementioned days would correspond to 
about phase III in Heitz et al. (1999). Concurrently, genu recurvatum (i.e., degree of knee 
hyperextension) and general joint laxity were significantly higher during the fifth luteal day, 
relative to the first day of menses. Unsurprisingly, the magnitude of cyclical changes were 
non-uniform among the cohort. In contrast, others have observed no significant difference in 
knee joint laxity across the menstrual cycle, among adolescent subjects (n=7, age 16.3 ± 
0.65-years) (Eiling, Bryant, Petersen, Murphy, & Hohmann, 2007).  
A few well-conducted trials have corroborated Eiling et al. (2007). In one study, 12-
eumenorrheic subjects were tested during the first day of menses, near ovulation, and at day 
23 of their menstrual cycle (i.e., midluteal). Luteinizing ovulation strips were utilized, to 
ascertain when the subjects ovulated. Furthermore, knee joint laxity was evaluated with the 
KTNM and radiographic measurements. The results indicated that although there were 
normal plasma fluctuations in T, E2, PG, LH, and follicle stimulating hormone (FSH), there 
was no significant difference in joint laxity between menstruation, ovulation, and midluteal 
phases (Van Lunen, Roberts, Branch, & Dowling, 2003). Likewise, others have noted no 
phase effect on knee joint laxity, but found that increases in knee joint laxity were associated 
with high knee joint loads which may precipitate injury (Park, Stefanyshyn, Ramage, Hart, & 
Ronsky, 2009a). 
 Dichotomously, other well-designed trials have favored an effect of phase on joint 
laxity. For instance, not only was knee joint laxity greater at ovulation, relative to the LP, but 
it was paralleled by increased knee joint loads (Park, Stefanyshyn, Ramage, Hart, & Ronsky, 
2009b). The aforesaid study recruited 25-subjects with a mean age of 22.7 ± 3.5-years. 
Moreover, in a similar cohort, although no differences were found in knee stiffness across the 
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menstrual cycle, knee laxity was highest during ovulation and the LP (Deie, Sakamaki, 
Sumen, Urabe, & Ikuta, 2002). In relation, others have noted both increases in knee laxity 
and reductions in stiffness during ovulation (Park, Stefanyshyn, Loitz-Ramage, Hart, & 
Ronsky, 2009c). Others have substantiated these findings by stating that anterior knee laxity, 
general joint laxity, and genu recurvatum were potentiated during the early luteal (EL) phase 
(Shultz et al., 2011).     
The best empirical trials have confirmed that knee laxity is affected by the menstrual 
cycle, as they measured knee laxity and endocrine parameters daily. For example, 22-
eumenorrheic females and 20-males were tested on the KTNM (Shultz et al., 2005). Serum 
E2, PG, and T were ascertained daily across one complete cycle for females, whereas the 
males were tested once per week for 4-weeks. Due to the divergent cycle lengths, the data 
was superimposed to when there was a similar hormonal milieu for all the female subjects; 
thus, allowing for the comparison of joint laxity and stiffness across similar hormonal 
concentrations and not during specific days of the menstrual cycle (e.g., comparing joint 
laxity during day 11 of the menstrual cycle when E levels may vary significantly across each 
subject). Although there were no differences in knee stiffness across or between the sexes, on 
average, females displayed greater laxity during the entirety of the menstrual cycle, relative 
to males. However, the values were not statistically significant during menses. Furthermore, 
within females joint laxity was greatest during ovulation, EL, and LL, with the highest values 
occurring during ovulation and EL (Shultz et al., 2005). Thus, the increased laxity in females 
was paralleled by the surge in E during MC and PG during EL. Congruently, in a similar 
design, nonathletic subjects (n=25, age 18 to 30-years) were tested daily while also 
conducting hormonal assays for E2, PG, and T (Shultz, Kirk, Johnson, Sander, & Perrin, 
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2004). Including the effect of time, the aggregate of E2, PG, and T and their interactions 
explained 63.3% of the variability in knee joint laxity. On average, the association was 
greater when variations in the hormonal environment were compared with alterations in knee 
laxity, which were taken 3-4 days after the assays. Thus, a latency period existed between the 
fluctuations in the hormonal milieu and variations in knee joint laxity (Shultz et al., 2004). 
Concurrently, knee laxity that is heightened during ovulation or the EL phase may necessitate 
lower and higher concentration of E and PG at the outset of the menstrual cycle, respectively; 
this improves the sensitivity of the collagen tissues to peak E and T levels (Shultz, 
Gansneder, Sander, Kirk, & Perrin, 2006). 
Therefore, there does appear to be increases in knee joint laxity during ovulation 
and/or shortly thereafter, which is significantly mediated by perturbations in endogenous 
hormones. Further, relative to males, laxity is heightened in the frontal (varus/valgus) and 
transverse (internal/external rotation) planes, while no difference is noted in the sagittal plane 
(flexion/extension) (Shultz, Pye, Montgomery, & Schmitz, 2012c). More so, the 
aforementioned were correlated with lower-limb lean mass (LLLM). However, there seemed 
to be significant inter-individual variability in the magnitude and timing of hormonal 
fluctuations and subsequently specifically, when laxity is altered. A delayed response to peak 
hormonal levels and/or the degree to which tissues are responsive to increases in endocrine 
parameters are the most plausible factors that explain the inter-individual increases in knee 
joint laxity. Elucidating when a subject will experience increases in knee joint laxity is 
possible when assays and knee laxity measurements are conducted daily.  
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2.6 Effects of the Menstrual Cycle on Joint Stiffness 
 
Similar to joint laxity, stiffness has also been demonstrated to be affected by the 
menstrual cycle; in comparison to men, this is especially evident in the frontal and transverse 
planes and is associated with LLLM (Shultz et al., 2012c). In part, this has been 
demonstrated to be mediated by perturbations in hormones, as there was a negative 
correlation between E2 and ACL stiffness (r=-0.80), whereas PG and estriol (r=0.70, r=0.66, 
respectively) were positively correlated with ACL stiffness (Romani, Patrie, Curl, & Flaws, 
2003). The aforesaid occurred during ovulation. Park et al. (2009a) observed significant 
reductions in knee stiffness during ovulation, in relation to the LP. Musculotendinous 
stiffness was significantly lower during the ovulatory phase, in relation to the first day of 
menses and day seven of the FP (Eiling et al., 2007). Moreover, Shultz et al. (2011) noted 
that varus-valgus stiffness was lower in females and was significantly reduced during the EL 
phase, in comparison to menses. The aforementioned information is pertient because 
attenuations in stiffness may predispose female athletes to injurious situations (Eiling et al., 
2007). Furthermore, stiffness is reduced during the same time interval that laxity is increased, 
which would accenuate an athletes risk to injuries. Interestingly, stiffness and laxity are 
perdominately affected in the frontal and transverse planes (Shultz et al., 2012c). Ergo, 
adduction, abduction, and rotational kinematic movement patterns should be limited during 
MC.    
2.7 Effects of the Menstrual Cycle on the Prevelance of Injuries  
 
Empirical evidence fails to demonstrate an increased prevelance of injuries during 
MC, when laxity and stiffness are increased and attenuated, respectively. In a prosepctive 
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study, male and female handball players were followed for one year, and although females 
sustained more ACL injuries (23 females vs. 5 males), they occurred at divergent time points 
during their menstrual cycle (Myklebust, Maehlum, Holm, & Bahr, 1998). Of the 23 injuries, 
all were of the non-contact variety and occurred while running at full speed or during cutting 
maneuvers (Myklebust et al., 1998). Specifically, five occurred during the menstrual phase, 
two in the folliular phase, one in the EL phase, and nine in the LL phase. However, hormonal 
assyas were not conducted and the phases were defined arbitrarily. Moreover, eight-women 
were on OC. Therefore, interpretation is limited. In relation, a retrospective study observed a 
greater inidence during ovulation (Wojtys, Huston, Lindenfeld, Hewett, & Greenfield, 1998). 
2.8 Oral Contraceptives and Athletic Performance 
 
In a similar manner to eumenorrheic non-OC adherent subjects, there has been 
conflicting data with regards to the effects of OC on a plethora of physiological parameters. 
Exogenous administration of synthetic hormones, in the form of a mono or triphasic OC 
regimen, has been demonstrated to homogenize hormonal levels, such that there are non-
significant differences across the phases of the menstrual cycle (Bell, et al., 2011; Redman & 
Weatherby, 2004). Moreover, circulating endogenous hormonal levels are significantly 
attenuated, relative to non-OC users (Devries et al., 2006). Therefore, the aforesaid hormonal 
milieu may negate the effects of the menstrual cycle, as hormonal levels remain fairly static. 
However, synthetic exogenous hormones are elevated (Ekenros, Hirschberg, Heijne, & 
Fridén, 2013), which are able to exert the same physiological stimulus as non-snthtetic 
isoforms. Subsequently, elucidating how synthetic hormones influence athletic performance 
is needed.  
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As such, evidence that substantiates the notion that OC negate the effets of the 
menstrual cycle are abundant. Bell et al. (2011) noted non-significant changes in muscle 
stiffness and hamstring neuromechanics. Concurrently, Sarwar et al. (1996) and Phillips et al. 
(1996) observed no cyclical changes in MVC and relaxation times from twitch and fused 
tetanus; Ekenros et al. (2013) documented no variations in muscle strength and power, in 
subjects on triphasic OC. Given that the menstrual cycle (i.e., non-OC) does not impact 
indices of strength, it is unlikely that OC influence strength across the menstrual cycle. 
Similarly, triphasic OC had no measurable effect on substrate utilzation (Jacobs et al., 2005).   
However, in women on OC, anaerobic performance was significantly greater on days 26-28 
of three consecutive menstrual cycles (Redman & Weatherby, 2004). Additional insight into 










The trial received IRB approval and prior to the outset, subjects signed the 
informed consent forum and completed the AHA/ACSM symptoms and menstrual cycle 
history questionnaire (See Appendix A-D). Prerequisites included a healthy body weight 
(BMI <25 kg/m2), normal menstrual cycle length, no oral contraceptive use within the 
prior six-months, and no orthopedic limitations.  
3.1 Study Design 
 
A causal-comparative study that investigated the effects of the menstrual cycle 
(independent variable) on agility (dependent variable) recruited eumenorrheic subjects 
(n=10) from Cleveland State University, to participate in a two-month study. Prior to the 
outset of the trial, subjects were familiarized with home-based urinary LH kits. During 
one month prior to and during the month of agility testing (i.e., second month) they 
completed the symptoms questionnaire, which consisted of menstrual cycle-related 
symptoms (e.g., breast tenderness, fluid retention, etc.). On a daily basis, the subjects
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input on the questionnaire whether they experienced the aforementioned symptoms. Also, 
during the allotted two-months on days 7-20 of their menstrual cycle, they utilized 
urinary LH kits to indirectly estimate the time of ovulation. LH kits more accurately 
predict ovulation, relative to BBT (Behre, 2001; Guermandi, et al., 2001). Ovulation 
occurs roughly 18-hours after the LH surge (Widmaier et al., 2011).  
All subjects completed testing during EF on days one through four of menses. 
Subsequent testing during MC was specific to each individual, as the estimated day of 
ovulation was predicated on the presence of a positive LH strip. During each session, the 
subjects were verbally and visually (i.e., the test administrator conducted each test) 
familiarized with the testing protocols. To improve objectivity, the administrator tested 
each subject. The subjects were instructed to wear the same shoes during each testing 
session, and the test administrator wore the same attire throughout the trial. Subjects were 
instructed to refrain from exercising 24 hours prior to the day of testing because the 
hormonal milieu can fluctuate after exercise (Frankovich & Lebrun, 2000). Similarly, 
subjects abstained from alcohol and caffeine intake during the allotted time. On entry into 
the lab, height and weight were measured on a wall-mounted stadiometer and physician 
scale, respectively. Afterwards, each subject conducted a dynamic warm-up for 10-
minutes, which consisted of five-minutes of light jogging and five-minutes of dynamic 
stretching, before the agility tests. The dynamic stretches were comprised of grapevines, 
shuffles, forward leg swings, and an external hip rotation stretch. Afterwards, they 
completed the T-Test and RAT sequentially; the order of which was counterbalanced. 
Congruently, to control for any order effects, counterbalancing was utilized when testing 
women during the two phases of the menstrual cycle. Testing was conducted in an indoor 
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testing center to minimize the effects of air density and wind velocity (McArdle, Katch, 
& Katch, 2009).  
3.2 Reactive Agility Test 
 
The RAT was selected for its ability to measure changes of direction and 
cognitive factors (e.g., anticipation, decision making speed, and decision making 
accuracy) (Sheppard, Young, Doyle, Sheppard, & Newton, 2006b). The RAT 
encompasses motor movements that are not pre-planned (i.e., open skills), which 
distinguishes this protocol from traditional closed skill agility tests (e.g., T-Test; 
movements that are preplanned). Therefore, ascertaining whether the menstrual cycle can 
impair cognitive function is more readily accomplished with open-skilled tests than 
closed skill tests. Test retest intra class coefficient (ICC) for the RAT was 0.878 
(Sheppard et al., 2006b). Similarly, reliability testing demonstrated a strong correlation 
between pre- and post-agility run times that were separated by seven-days (r=0.91), 
which indicates no learning effect (Veale, Pearce, & Carlson, 2010).  
During the RAT (See Appendix E), the subjects emulated the sport specific 
movement patterns of the tester. The teste administrator was situated in proximity to a 
motion sensor while the subjects stood five-meters directly across. Directly parallel to the 
subject and the tester (five-meters to the left and right) were two timing gates. The test 
commenced once the tester initiated the movement and stepped away from the sensor. 
The subjects then reacted to the movement patterns of the test administrator and executed 
the movements to the best of their ability. The time was stopped when the subject passed 
the timing beam on the left or the right. For example, when the test administrator moved 
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forward and to the left, the subject would have, likewise, performed the same movement 
patterns until the beam on the left was triggered. As presented by Sheppard et al. (2006b), 
each movement was executed twice and the fastest time for each movement pattern was 
utilized. The movement patterns were comprised of: 
1) Step forward with the right foot and change direction to the left. 
2) Step forward with the left foot and change direction to the right. 
3) Step forward with the right foot, then left, and change direction to the right. 
4) Step forward with the left foot, then right, and change direction to the left.  
The test administrator, however, was instructed to perform all of the aforesaid 
movements in each testing session. The order of which was randomized for each session.  
3.3 T-Test 
 
 In contrast, the T-Test utilizes four cones that are dispersed in the shape of a “T” 
(See Appendix F). A motion sensor was placed near the right foot of each subject and a 
timing gate was placed 0.56-meters behind the subject. The subject initiated the test at 
cone A and sprinted to cone B, which was located 10-yards ahead and touched the base 
of the cone with their right hand. Thereafter, they shuffled five-yards to the left and, 
congruently, touched the base of cone C with their left hand. Afterwards, they shuffled to 
the right 10-yards and touched the base of cone D with their right hand. Once they 
initiated contact with cone D, they shuffled back to cone B and touched the base of the 
cone with their left hand. Finally, the subject backpedaled from cone B to cone A, and the 
time was stopped when the subject passed the timing gate. Criteria for disqualification 
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included failing to touch the base of the cone, overlapping the feet while shuffling, and 
failure to maintain a neutral head position throughout.  
3.4 Statistical Analysis 
 
Inferential statistics were used to assess treatment differences due to menstrual 
cycle phase on agility run times. Level of significance was set at p=<0.05. A per-protocol 
(PP) and intent-to-treat analysis (ITT) were conducted; ITT analysis included all subjects 
in the analysis post-randomization, while the PP analysis omits subjects who committed 
protocol violations. Differences between continuous variables were analyzed with a 
paired samples t-test and expressed in mean values (± standard deviation [SD]). Data was 











Due to protocol deviations, an ITT and PP analysis were conducted. The latter 
resulted in the exclusion of two subjects. Specifically, subject seven was tested in a 
divergent setting, whilst the eighth wore different shoes during MC and EF. As depicted 
in figure one and table one, the PP analysis demonstrated that there was a significant 
difference in T-Test agility times between MC and EF (12.56 ± 0.90-s vs. 12.3 ± 0.89-s, 
p=0.007), while the ITT analysis did not note a significant difference (12.76 ± 1.15-s vs. 
12.89 ± 1.65-s, p=0.623). For more robust conclusions to be drawn, mutual agreement, or 
at least a degree of similarity, between the forms of analysis should be apparent. This was 
observed with the RAT however; with both analyses noting non-significant differences.  
As shown in table one, for PP and ITT analysis, no differences were noted in 
RAT agility times between EF and MC for any of the movements. Specifically, PP 
median values for RAT maneuvers 1-4 were not different across the phases.  
For ten-subjects (BMI 22.4 ± 1.4-kg/m2; weight 61.3 ± 5.6-kg; age 24.2 ± 5-years; 
height 165.58 ± 8.29-centimeters), there was no significant difference (p=0.49) in weight 
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between EF (61.2 ± 5.5-kg) and MC (61.4 ± 6-kg). The mean cycle length was 28 ± 3-
days, and subjects experienced a LH surge on day 15 ± 2.8. The mean LP length was 12.6 
± 3.4-days. Age of menarche occurred at 13 ± 2.3-years. 
Table 1. The Effects of the Menstrual Cycle on Agility Times Attained on the 
RAT and T-Test 
 
Protocol Mid-Cycle Early Follicular Phase p-value 
T-Test (P) 12.56 ± 0.90-s 12.3 ± 0.89-s 0.007 
T-Test (I) 12.76 ± 1.15-s 12.89 ± 1.65-s 0.623 
RAT 1 (P) 1.87 ± 0.090-s 1.91 ± 0.13-s 0.350 
RAT 2 (P) 1.97 ± .015-s 1.96 ± 0.11-s  0.807 
RAT 3 (P) 1.99 ± 0.86-s 2.04 ± 0.17-s 0.374 
RAT 4 (P) 2.15 ± 0.22-s 2.06 ± 0.18-s 0.258 
RAT 1 (I) 1.92 ± 0.16-s 1.95 ± 0.18-s 0.438 
RAT 2 (I) 2.01 ± 0.21-s 2 ± 0.16-s 0.616 
RAT 3 (I) 2.05 ± 0.16-s 2.05 ± 0.18-s 1 
RAT 4 (I) 2.18 ± 0.23-s 2.11 ± 0.23-s 0.295 
I= intent-to-treat analysis (n=10); P=per-protocol analysis (n=8). p-values: Paired 
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Figure 1. During a per-protocol analysis (n=8), a paired samples t-test was conducted to 
elucidate if there was an effect of menstrual cycle phase on agility performance. As 
depicted, subjects were significantly faster during menses (12.3 ± 0.89-seconds), relative 


































Given that subjects were significantly faster during menses in comparison to mid-
cycle, the hypothesis was refuted. As such, the principal and novel outcome from this 
trial was that agility performance may be influenced by the menstrual cycle during agility 
tests that do not require mental processing. To the knowledge of the author, no empirical 
trial has investigated how the menstrual cycle influences agility. The results affirm that 
mental processing, when executing athletic maneuvers, may not be affected by 
fluctuations in E; given that agility times did not differ between RAT values attained 
during menses versus MC. This is in contrast to the noted effect on cognitive function at 
rest (Rosenberg et al., 2002; Wolf et al., 1999). The discrepent finding may be due to the 
diverse testing environment; the current trial being in an athletic setting, while that of the 
aforesaid was in the rested state. Moreover, the protocols were on the opposite ends of 
the spectrum, with respect to assessing cognitive function; Wolf et al. (1999) and 
Rosenberg et al. (2002) studied how verbal memory was influenced, while the present 
study elucidated if mental processing during agility drills was affected.  
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A possible explanation for the lack of a significant finding between agility times 
attained during MC versus EF during the RAT relates to the fact that it requires only one 
or two change of direction movements. In relation, the T-Test consists of four change-of-
direction movements, along with accelerating, decelerating, shuffling, and back-pedaling 
motions. However, the neuromuscular system has not been noted to be affected by the 
menstrual cycle, which makes it unlikely that perturbations in E had an effect on strength, 
power production, deceleration, or acceleration (Dibrezzo et al., 1991; Elliott et al., 2003; 
Friden et al., 2003; Janse de Jong et al., 2001; Lebrun et al., 1995). Thus, the aforesaid 
did not likely contribute to deviations in T-Test times. Body weight also had a negligible 
contribution to agility times, as there were non-significant differences between EF and 
MC.  
 With respect to the endocrine system, potentiated levels of E could have hindered 
athletic performance while performing change of direction movements, as indicated by 
the T-Test. Dichotomously, PG may not have played a significant role, given that 
concentrations remain low during EF and MC, which is when agility testing was 
conducted. This would indicate that PG would not have been able to antagonize the 
actions of E (Romani et al., 2003), but sensitizing collagen to E during the MC surge may 
require requisite low and high levels of E and PG during menses, respectively (Shultz et 
al., 2006).  
Corroborating the link between the menstrual cycle, knee laxity, and altered 
biomechanical patterns are made by several empirical trials: the menstrual cycle has been 
noted to affect knee laxity, which has been demonstrated to alter biomechanical patterns 
and possibly have a subsequent effect on agility performance (Shultz et al., 2012a; Shultz 
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et al., 2005). Indeed, the aggregate of E2, PG, and T explained 63% of the variation in 
laxity (Shultz et al., 2004). Subsequently, the association between laxity, an altered 
biomechanical profile, and agility is multifaceted. It is likely that a myriad of hormones 
and other innate factors contributed to the variance in agility performance. There is likely 
to be large inter-individual differences, given that the level and timing of surges in 
circulating endogenous hormones are widely different between subjects. Consequently, 
only a general time point can be pinpointed as to when laxity, biomechanical patterns, 
and agility performance appears to be most negatively affected: MC. This would 
correspond to ovulation and the early segments of the LP. However, it is equally likely 
that this may extend into the LL phase.        
With respect to athletes, curtailing their exercise regimen during the aforesaid 
time points may be necessary, given that stiffness is also attenuated during MC (Shultz et 
al., 2012c). Therefore, for optimal reductions in injury risk and improved athletic 
performance, athletic competitions, if possible, may need to be conducted during the EF 
and LL phase. Congruently, intensity and/or volume of exercise may need to be curtailed 
during MC, as laxity and stiffness are heightened and attenuated, respectively. A 
deterrent to injurious situations would be to increase muscle mass (Shultz et al., 2012c), 
overall muscular strength, and correcting ipsilateral and contralateral strength deficits. 
This would not only entail prescribing the typical sport specific movement exercises, but 
also single-joint exercises (e.g., knee curls, hip abduction exercises, etc.), which are 
needed to correct muscular imbalances.    
LP suppression (a truncated LP) is a possible marker of infertility and 
consequently attenuated levels of ovarian hormones (PCASRM, 2012). As indicated by 
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the results, there was no indication of luteal phase suppression and the subjects were 
noted to have normal menstrual function. The mean LP length was 12-days, but 
individuals with LP suppression usually have a LP length of < 10-days. 
5.1 Limitations  
The principal limitation was the omission of hormonal assays. Furthermore, 
conducting agility drills during ovulation is difficult to isolate because it represents a 
physiologically condensed time interval. More specifically, its duration is limited as it 
only peaks for approximately three days (Landgren, Undén, & Diczfalusy, 1980). 
Ultradian rhythm variations in hormones could skew effects of the menstrual cycle phase 
on agility times. Lastly, increased E levels may not immediately influence physiological 
parameters (Phillips et al. 1996). A finite sample size (n=8) limits the ability to make 
broad generalizations.    
5.2 Future Considerations and Conclusions 
 
There does appear to be an effect of the menstrual cycle on agility. Specifically, 
agility performance is hindered during MC, when the corresponding surges in E occur. 
This is likely the result of increases in joint laxity and its associated alterations in 
biomechanical patterns. Future trials should conduct hormonal assays and agility trials 
daily; measuring the effects of the menstrual cycle by only conducting trials during 2-3 
time points during the cycle only gives a small representation of how fluctuations in 
endogenous hormones influence agility. As is frequently conducted, two to three 
snapshots of perturbations in hormones and the congruent effects on athletic performance 
are not sufficient to make conclusive inferences. 
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INFORMED CONSENT FOR PARTICIPATION 
 
 
Effects of Menstrual Cycle on Agility Performance 
 
Introduction  
Thank you for considering participation in this project.  Professor Emily Kullman, faculty 
in the Department of Health and Performance, and Mr. Karim Kheniser, Graduate 
Student in the Exercise Science Program, Department of Health and Performance at 
Cleveland State University are inviting you to participate in a research study to be 
conducted in the Human Performance Laboratory at Cleveland State University, which is 
located in room PE59. The study is being conducted to complete Mr. Kheniser’s master’s 
thesis.  
 
The purpose of this study is to observe the effects of menstrual cycle, and particularly 
estrogen levels, on agility performance. 
 
There is some evidence to suggest that estrogen affects joint laxity, which may have 
negative influences on joint mobility, and subsequent agility performance during the days 
of the menstrual cycle when estrogen levels are low. This, in turn, may result in impaired 
sports performance, or potential injury. 
 
By determining if low estrogen levels does in fact cause a decline in sports performance, 
and potentially put the athlete at greater risk for injury, we can begin to develop specific 
training programs aimed at improving agility performance throughout the menstrual 
cycle; thus, providing better recommendations regarding injury prevention among female 
athletes. 
 
You will be asked to complete two exercise sessions as part of this study at the Cleveland 
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State University Human Performance Laboratory. Each session will consist of a brief 
warm-up, followed by two separate agility tests. One test will be the T-Test, which 
consists of a T-shaped running and shuffling pattern on a pre-determined course.  The 
second test is the reactive agility test (RAT), during which you will be emulating the 




Prior to completion of the agility tests, you will be asked to monitor your menstrual cycle 
for one complete cycle using a questionnaire related to your symptoms, as well as a 
home-based ovulation test kit, which monitors urinary excretion of Luteinizing Hormone 
(LH). The ovulation kits will be provided to you by the study team to complete in the 
convenience of your own home. We will use these tests to establish proper timing of the 
agility tests during your next cycle.  
 
Once your menstrual cycle patterns have been determined, we will establish testing dates 
to correspond with low-estrogen, and high-estrogen time points during your following 
menstrual cycle.  The low-estrogen trial will be performed 2-4 days after the start of your 
menses.  The high-estrogen trial will be performed approximately 2-3 days before your 
established ovulation date based on the previous month’s ovulation test kit and 
questionnaires. You will also be asked to come to the HPL for familiarization with the 
agility testing procedures prior to your study testing dates.  Each HPL visit will require 
~1 hour of your time, for a total of 3 hours throughout the study. 
 
For each of the two study testing dates, you will be asked to come to the HPL, where a 
venous blood sample will be obtained to verify estrogen levels. Following the blood 
draw, you will perform a brief warm up consisting of 5 minutes of light jogging, and 5 
minutes of dynamic stretching. A warm-up will be followed by the agility testing 
protocols, including the T-Test and the RAT.  These tests will be performed in random 
order. The T-Test consists of a T-shaped running and shuffling pattern on a pre-
determined course, and you will perform this test one time.  The second test is the 
reactive agility test (RAT), during which you will be emulating the movement pattern of 
the tester, and we will require you to do this 4 times. Both of these tests will be timed to 
monitor agility performance, with the goal of completing these tests in the fastest time 
possible. 
 
Risks and Discomforts 
Risks associated with this study include muscle soreness from the completed agility tests. 
There may be joint discomfort at the ankle, knee, and hip due to the abrupt movements of 
the agility tests. There may be some discomfort in the arm in which the blood sample is 
taken from. Due to the nature of the agility tests, there is risk of tripping or falling.  As a 
result of a fall, the attendant risks include: bone fractures, torn ligaments, muscle strains, 
joint sprains, bruises or joint dislocations.  Furthermore, although each of these tests lasts 
~10-20 seconds, an all-out effort will be required and in rare instances could lead to 
fainting, abnormal blood pressure, fatal heart rhythms, stroke or heart attack. 
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Benefits 
The indirect benefits of the study are to help your understanding of how menstrual cycle 
hormone fluctuations may play a role in exercise performance. There are no guaranteed 
direct benefits, but this study may help you in knowing how to maximize your fitness 




To protect your privacy, your name will not be used in any document of the project. A 
number will be assigned to the subject in place of a name. The information, however, 
may be used for a statistical or scientific purpose with your right of privacy retained. 
Professor Emily Kullman and Karim Kheniser will be the only witnesses of the 
information being presented. Data will be stored in the Human Performance Lab PE60B 
in a locked filing cabinet.  
 
Participation  
I understand that participation in this project is voluntary and that I have the right to 
withdraw at any time with no consequence. I attest and verify that I have no known 
health problems that could prevent me from successfully participating in the interval 
protocol treadmill test. If I have any questions about the procedures I can contact 
Professor Emily Kullman at (216) 687-4854 or Mr. Karim Kheniser at (440) 796-0056.  
 
I understand that if I have any questions about my rights as a participant, I can contact 
Cleveland State University’s Review Board at (216) 687-3630. 
 
Participant Acknowledgement  
The procedure, purposes, known discomforts and risks, possible benefits to me and to 
others have been explained to me. I have read the consent form or it has been read to me, 


























At what age did you first begin menstruating? 




Section 1 Yes No 
1. Is your menstrual cycle generally shorter than 26 days?   
2. Is your menstrual cycle generally longer than 31 days?   
3. Do you experience irregular bleeding during your cycle?   
4. Do you ever miss periods or have changes in the frequency or duration 
of your menstrual cycle? 
  
5. Does stress make your menstrual cycle length more irregular?    
6. Has chronic stress, increasing age or exercise changed the regularity of 
your period or stopped your period altogether?  
  
7. Do you experience sharp, stabbing, or dull aching pains mid-cycle 
which is worse when you apply pressure? 
  
Section 3 Yes No 
1. Have you been medically diagnosed with endometriosis?   
2. Have you been medically diagnosed with uterine fibroids?   
3. Have you been medically diagnosed with ovarian cysts?   
4. Have you been medically diagnosed with pelvic adhesions or masses?   
5. Have you been medically diagnosed with polycystic ovarian syndrome?   
6. Do you experience very heavy periods and/or acne?   
Section 2 Yes No 
1. Do your periods last less than 3 days?   
2. Do your periods last more than 5 days?   
  








Asses your health needs by marking all true statements. 
 
History:  You have had:     Name:   
__ a heart attack 
__ heart surgery      Date: 
__ cardiac catheterization 
__ coronary angioplasty (PTCA) 
__ pacemaker/implantable cardiac defibrillator/rhythm disturbance 
__ heart valve disease 
__ heart failure 
__ heart transplantation 
__ congenital heart disease 
 
Symptoms: 
__ You experienced chest discomfort with exertion. 
__ You experience unreasonable breathlessness. 
__ You experience dizziness, fainting, blackouts. 
__ You take heart medications. 
 
Other health issues: 
__ You have musculoskeletal problems. 
__ You have concerns about the safety of exercise. 
__ You take prescription medication(s). 
__ You are pregnant. 
 
If you marked any of the statements in this section, consult your healthcare provider 
before engaging in exercise. You may need to use a facility with a medically qualified 
staff. 
 
Cardiovascular Risk Factors: 
__ You are a man older than 45 years. 
__ You are a woman older than 55 years or you have had a hysterectomy or you are post- 
menopausal. 
__ You smoke. 
__ Your blood pressure is > 140/90. 
__ You don't know your blood pressure. 
__ You take blood pressure medication. 
__ Your blood cholesterol level is > 240 mg/dl. 
__ You don't know your cholesterol level. 
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__ You have a close blood relative who had a heart attack before age 55 (father or 
brother) or age 65 (mother or sister). 
__ You are physically inactive (ie, you get < 30 minutes of physical activity on at least 3 
days per week. 
__ You are > 20 pounds overweight. 
 
If you marked 2 or more of the statements in this section, consult your healthcare 
provider before engaging in exercise. You might benefit by using a facility with a 
professionally qualified exercise staff to guide your exercise program. 
 
__ None of the above is true. 
 
You should be able to exercise safely without consulting your healthcare provider in 
























REACTIVE AGILITY TEST 
 
 



























ACL, anterior cruciate ligament;  
E2, estradiol;  
E, estrogen;  
PG, progesterone;  
T, testosterone;  
GH, growth hormone;  
EF, early follicular phase;  
MC, mid-cycle;  
RAT, reactive agility test;  
LH, luteinizing hormone;  
OC, oral contraceptives;  
MVC, maximal voluntary contraction;  
ML, mid-luteal phase;  
FP, follicular phase,  
LP, luteal phase;  
PP, per-protocol;  
ITT, intent-to-treat analysis;  
LL, late luteal;  
PTS, percutaneous twitch superimposition;  
AP, adductor pollicis muscle;  
MVF, maximal voluntary force;  
KTNM, KT-200 knee arthrometer;  
Vo2max, maximal oxygen consumption;  
ICC, intra class coefficient 
 
